Zimbabwe has rejected a major US health deal worth $367m (272 million pounds) spanning five years because of Washington's insistence on confidential biological samples.
This move was revealed following a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
A government spokesman later clarified that the US was seeking biological samples for scientific study and commercial purposes while was unwilling to guarantee the benefits from future medical innovations.
"We will now turn to the challenging and unfortunate task of scaling back our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged more talks to find a deal agreeable to all parties so the nation's vital HIV programme can continue.
Wider Background
This rejection comes after a similar situation in Kenya, where a court suspended a similar health funding agreement following legal challenges were raised about the safety of Kenyans' health data.
Since resuming office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the US government, but Trump claimed its spending was "wasteful" and his administration was seeking government-to-government agreements to enhance openness and accountability.
According to statements, Sixteen African countries have to date agreed to similar health pacts, constituting over $18.3bn in committed funds.
Specifics of the Rejected Deal
This assistance for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership might have yielded extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving antiretroviral therapy via US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"Our nation was requested to share its genetic material and health information for a long time, without any equivalent promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"Put simply, our country would provide the raw materials for medical research without any assurance that the final treatments would be available to our citizens if a future disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the global health body and its pursuit of one-on-one health agreements were upending frameworks previously established through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing scheme created to deal with potential pandemics.
"This framework is designed to ensure that when a country contributes its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome ongoing discussions with our American counterparts on how subsequent co-operation might be designed in a manner that honours the independence and interests of each country."
Medical Community Response
A leading public health body expressed it acknowledged the government's concerns, but urged that negotiations must proceed given that much of the country's HIV programmes relied on external financing.
"In cases where specific concerns exist, including those involving data governance or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," it commented.
The halted deal highlights the ongoing tensions between accepting crucial international aid and protecting local interests in an increasingly interconnected world.